




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報或認(rèn)領(lǐng)
文檔簡介
1、Translational Medicine & Precision Medicine轉(zhuǎn)化醫(yī)學(xué)和精準(zhǔn)醫(yī)學(xué)廣東省肺癌研究所 Guangdong Lung Cancer Institute循證醫(yī)學(xué)雜志 Journal of Evidence-based MedicineTranslational Medicine & PreClinical Research: NIH DefinitionEpidemiologic and behavioral studiesOutcomes research and health services research Patient-oriented resear
2、ch - Research conducted with human subjects, tissues, specimens, or cognitive phenomena for which an investigator directly interacts with human subjects Healthy volunteer: person with no known significant health problem who participates in clinical research to test a drug, device, or interventionCli
3、nical Research: NIH DefinitClinical TrialsA prospective study involving human subjects that is designed to answer specific questions about the effects or impact of particular biomedical or behavioral interventionsNOT healthy volunteer studies, which are designed to develop new knowledge, but provide
4、 no direct benefits to the subjectsClinical TrialsA prospective sTranslational Research: NIH DefinitionThe process of applying discoveries generated during research in the laboratory, and in preclinical studies, to development of trials and studies in humansLeveraging the observations made in clinic
5、al practice to drive new mechanistic investigations at the bench Enhancing the adoption of best practices in the communityTranslational Research: NIH DeBackgroundIn the past 30 years,NCI $200 BillionsResults:1.56million articles80 on mice, fruit fly and round worm。No change on cancer related mortali
6、ty rateBackgroundIn the past 30 yearsBackgroundBackgroundBackgroundNew biotechnologyGenomics(基因組), Proteomics(蛋白質(zhì)組)Bioinformatics(生物信息學(xué))Increasing complexity of clinical researchBackgroundNew biotechnologyDefinitionTranslational research, “transforms scientific discoveries arising from the laborator
7、y, clinical, or population studies into clinical applications”Include:bench to bedside(基礎(chǔ)研究到臨床應(yīng)用)bedside to bench(臨床治療結(jié)果促進(jìn)基礎(chǔ)研究)Source: National Cancer Institute, National Institutes of HealthDefinitionTranslational researBasic and Clinical Research are InterdependentTranslation from basic science to
8、 human studiesTranslation ofnew knowledgeinto clinical practiceBasicResearchClinical ResearchImprovedHealthAdapted from Sung et al. (2003) JAMA, 289, 1278-89. Copyright (2003) American Medical Association. All Rights reserved.“T1”“T2”The production of a promising new treatment/method that can be use
9、d clinically or commercialized. Ensure that new treatments and research knowledge actually reach the patients or populations for whom they are intended and are implemented correctlyBasic and Clinical Research arTranslational MedicineTranslate the success in genomic medicine into clinical application
10、sEvidence-based medicine develop rationale and theory for drug design and therapeutic interventionDevelop personal medicine and preventive medicineTranslational MedicineTranslatTranslational MedicineTranslational Research -hot spotGenomic and gene diagnosis and treatment基因組研究及基因診斷治療Phase I trial for
11、 drugs 藥物一期臨床試驗Genomic Pharmocology and personalized medicine 基因組藥理學(xué)與個體化醫(yī)學(xué)Biomarks 生物標(biāo)記物Signal transducting pathway and clinical applications 信號傳導(dǎo)通路的研究及其臨床應(yīng)用Stem cell干細(xì)胞Translational MedicineTranslatTranslational MedicineThe heart of translational research resides in Phase I trials where novel treat
12、ments are :tested for feasibility and toxicitypreparation for a Phase II trial in which therapeutic effectiveness is testedMarincola, FMTranslational Medicine: A two -w ay road, JTM, 2006Translational MedicineThe hearClinical Research Training ProgramComputer SkillsClinical Research MethodsBiostatis
13、tics: Statistical Approach in Clinical ResearchMeasurements in Clinical ResearchEthics and Regulations of Clinical ResearchResearch Design and DevelopmentCost-effectiveness AnalysisRegression and ANOVALogistic RegressionClinical TrialsClinical Research Training ProEarly study on nitric oxide Synthas
14、eEarly study on nitric oxide SyUses for a cloned geneHomology comparisonQuantitate gene expressionChromosomal mappingDetermine transcriptional regulationPrepare recombinant proteinAntibody developmentTissue localizationDevelop transgenic/knockout animalsGene transfer/gene therapy studiesIntellectual
15、 property / technology transferUses for a cloned geneHomologydme臨床科研設(shè)計與評價轉(zhuǎn)化醫(yī)學(xué)和精準(zhǔn)醫(yī)學(xué)translational-medicine課件Explore Gene and DiseasesExplore Gene and Diseasesdme臨床科研設(shè)計與評價轉(zhuǎn)化醫(yī)學(xué)和精準(zhǔn)醫(yī)學(xué)translational-medicine課件Physiopathological StudyBench:Vasoprotective Properties of Nitric OxideInhibits platelet aggregatio
16、nInhibits leukocyte chemotaxisInhibits VSMC proliferationInhibits VSMC migrationPromotes EC growthInhibits EC apoptosisPotent vasodilatorPhysiopathological StudyBench:Cell and AnimalAdenoviral Vector (type 5, E1-, E3-)腺病毒載體Cell and AnimalAdenoviral VectSmall AnimalsSmall AnimalsBigger AnimalsBigger
17、AnimalsAnimal Experiment2005年Animal Experiment2005年dme臨床科研設(shè)計與評價轉(zhuǎn)化醫(yī)學(xué)和精準(zhǔn)醫(yī)學(xué)translational-medicine課件PhaseClinical TrialClinical Trial: AdiNOS gene therapy to block AV fistula neointimal hyperplasia in hemodialysis patients2006PhaseClinical TrialClinical TCurrent State of Translational Medicine17 year in
18、novation adoption curve from discovery into accepted standards of practiceEven if a standard is accepted, patients have a 50:50 chance of receiving appropriate care, a 5-10% probability of incurring a preventable, anticipatable adverse eventThe market is balking at healthcare inflation, new diagnost
19、ics and therapeutics will find increasing resistance for reimbursementCurrent State of TranslationalPrecision medicine 2015-1-20Precision medicine 2015-1-20Precision MedicinePrecision Medicine(personalized medicine): a form of medicine that uses information about a persons genes, proteins, and envir
20、onment to prevent diagnose, and treat disease.(NCI) Specific markers diagnose & treatment decisions Precision Cancer Medicine(PCM )Right DrugRight PatientRight TimeRight DoseMolecular eventKnowledgedecisionClinical TrialPrecision MedicinePrecision MeImatinib for GISTGIST genesis Key process: c-kit m
21、utation-KIT TK activationPDGFR mutation86% GIST kit mutation,prognosis factorImatinibOral small molecule TKIInhibit TK activation抑制酪氨酸激酶活化Design for chronic myeloid leukemia (CML)Imatinib for GISTGIST genesis Imatinib for GISTImatinib for GISTImatinib for GISTJoensuu H,et al. 2001Imatinib for GISTJo
22、ensuu H,et PretreatmentOne month of therapyH&E (at diagnosis)H&EKi 67CD117Joensuu H et al. N Engl J Med. 2001;344:1052-1056.The First GIST Patient: HistologyImatinib for GISTPretreatmentOne month H&E (at Imatinib for GISTJoensuu H,et al. 2001Theory:Imatinib could target GISTEasy Detected tumor marke
23、r:CD117Tissue from the patientResponse confirmed by pathology Dynamic monitored by tumor markerEthics:IRBImatinib for GISTJoensuu H,et Imatinib 治療 GIST2000.3: Joensuu H. first case2000.7: phase II study(B2222) 2001 autumn:phase II study (S0033,EORTC)2002.2:FDAImatinib 治療 GIST2000.3: Joensudme臨床科研設(shè)計與
24、評價轉(zhuǎn)化醫(yī)學(xué)和精準(zhǔn)醫(yī)學(xué)translational-medicine課件Imatinib for GIST5-year survivalKit mutation predict Imatinib responseImatinib for GIST5-year survivImatinib for GISTImatinib for GISTImatinib for GISTImatinib resistance cliniclabOvercome Imatinib resistance lab clinicMechanism of Imatinib resistance cliniclabImatinib for GISTImatinib resiImatinib for GISTSurgery in advance GISTWhen to stop?Imatinib for GISTSurgery in adChois Imatinib for GISTChoi et al, J Clin Oncology, 2007;25:1753-1759Chois Imatinib for GISTChoi eImatinib for GISTC-kit a
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 2025年軍隊文職人員招聘之軍隊文職教育學(xué)綜合檢測試卷A卷含答案
- 2022年遼寧省沈陽市生物中考真題(含答案)
- 中小學(xué)教師學(xué)生心理健康教育及案例分析
- 2025年法律知識學(xué)習(xí)競賽必考題庫及答案(60題)
- 產(chǎn)品銷售記錄表-網(wǎng)絡(luò)銷售
- 農(nóng)村生態(tài)農(nóng)業(yè)示范區(qū)協(xié)議書
- 活動策劃簡報
- 健康飲食指南制作流程表格
- 安徽省阜陽市太和縣2024-2025學(xué)年七年級上學(xué)期期末生物學(xué)試題(含答案)
- 合同執(zhí)行與收款進(jìn)度跟蹤表
- 2025年中國羊毛絨線市場調(diào)查研究報告
- 肥料登記申請書
- 礦產(chǎn)勘探數(shù)據(jù)分析-深度研究
- 人教版高中英語挖掘文本深度學(xué)習(xí)-選修二-UNIT-4(解析版)
- 2025年北京控股集團(tuán)有限公司招聘筆試參考題庫含答案解析
- 2024年07月江蘇銀行招考筆試歷年參考題庫附帶答案詳解
- 2025中智集團(tuán)招聘重要崗位高頻重點提升(共500題)附帶答案詳解
- 2025年人事科年度工作計劃
- 2023-2024學(xué)年高中信息技術(shù)必修一滬科版(2019)第二單元項目三《 調(diào)查中學(xué)生移動學(xué)習(xí)現(xiàn)狀-經(jīng)歷數(shù)據(jù)處理的一般過程》說課稿
- 院感知識手衛(wèi)生培訓(xùn)內(nèi)容
- 【MOOC】計算機(jī)組成與CPU設(shè)計實驗-江蘇大學(xué) 中國大學(xué)慕課MOOC答案
評論
0/150
提交評論